StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $82 at Bernstein SocGen Group
May 5, 2026 6:00 AM
Bernstein SocGen Group analyst William Pickering lowered the price target on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
